These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11943279)

  • 1. Drug firms' representatives express concern over WHO's AIDS drug list.
    Kapp C
    Lancet; 2002 Mar; 359(9312):1134. PubMed ID: 11943279
    [No Abstract]   [Full Text] [Related]  

  • 2. WHO pulls Indian generics off AIDS drugs list.
    Nat Med; 2004 Sep; 10(9):885. PubMed ID: 15340402
    [No Abstract]   [Full Text] [Related]  

  • 3. AIDS treatment. A step toward cheaper anti-HIV therapy.
    Cohen J
    Science; 2005 Feb; 307(5710):653. PubMed ID: 15692020
    [No Abstract]   [Full Text] [Related]  

  • 4. AIDS treatment. Drugmakers test restrictions on generics in U.S. programs.
    Cohen J
    Science; 2004 Oct; 306(5694):213. PubMed ID: 15472049
    [No Abstract]   [Full Text] [Related]  

  • 5. Two AIDS medicines back on WHO prequalification list.
    Wkly Epidemiol Rec; 2004 Dec; 79(50):449-50. PubMed ID: 15646322
    [No Abstract]   [Full Text] [Related]  

  • 6. WHO pulls two generic AIDS drugs from approved list.
    Fleck F
    BMJ; 2004 Jun; 328(7455):1518. PubMed ID: 15217863
    [No Abstract]   [Full Text] [Related]  

  • 7. Innovation and the WHO's essential medicines list: giving credit where credit is due.
    Wertheimer AI; Santella TM
    Res Social Adm Pharm; 2007 Mar; 3(1):137-44. PubMed ID: 17350562
    [No Abstract]   [Full Text] [Related]  

  • 8. Indian company seeks US approval for generic AIDS drugs.
    Nature; 2004 Aug; 430(7001):716. PubMed ID: 15306779
    [No Abstract]   [Full Text] [Related]  

  • 9. WHO drops two generics from approved HIV drugs list.
    Khan A
    Lancet; 2004 Jun; 363(9427):2147. PubMed ID: 15222328
    [No Abstract]   [Full Text] [Related]  

  • 10. WHO's AIDS drug goal unlikely to be met.
    Nat Med; 2005 Aug; 11(8):813. PubMed ID: 16079864
    [No Abstract]   [Full Text] [Related]  

  • 11. World Trade Organization still threatens supply of affordable AIDS drugs.
    Hagmann M
    Bull World Health Organ; 2002; 80(9):762-3. PubMed ID: 12378300
    [No Abstract]   [Full Text] [Related]  

  • 12. Generic capsule form HIV/AIDS drug.
    FDA Consum; 2006; 40(4):3. PubMed ID: 17243276
    [No Abstract]   [Full Text] [Related]  

  • 13. Several AIDS drugs tentatively approved.
    FDA Consum; 2005; 39(5):3. PubMed ID: 16421982
    [No Abstract]   [Full Text] [Related]  

  • 14. Tobias, W.H.O. at odds over drug standards.
    Med Health; 2004 Mar; 58(13):2-3. PubMed ID: 15088496
    [No Abstract]   [Full Text] [Related]  

  • 15. USA urged to accept generic AIDS drugs.
    Nelson R
    Lancet; 2004 Apr; 363(9416):1205. PubMed ID: 15083821
    [No Abstract]   [Full Text] [Related]  

  • 16. Amendments to the Canadian Patent Act to address drug access: is help on the way?
    Penner MD; Narayanan P
    Food Drug Law J; 2005; 60(3):459-70. PubMed ID: 16304751
    [No Abstract]   [Full Text] [Related]  

  • 17. 100th HIV/AIDS antiretroviral drug approved by PEPFAR.
    AIDS Patient Care STDS; 2009 Nov; 23(11):988-9. PubMed ID: 19938372
    [No Abstract]   [Full Text] [Related]  

  • 18. South Africa may keep door closed to generic AIDS drugs.
    Cherry M
    Nature; 2001 Apr; 410(6832):1013. PubMed ID: 11323627
    [No Abstract]   [Full Text] [Related]  

  • 19. Patent infringement. Generic HIV drugmaker's patent claim is time-barred.
    AIDS Policy Law; 2003 Aug; 18(16):6. PubMed ID: 14626916
    [No Abstract]   [Full Text] [Related]  

  • 20. WHO's poor consultation with patients on HIV guidance has denied women choice in drug treatment.
    Welbourn A
    BMJ; 2014 Feb; 348():f7601. PubMed ID: 24508753
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.